New insights into regulation of human T-cells
T –cells are central regulators of proper immune response. They can specialize to functionally distinct subsets and aberrations in their proper function results in inflammatory and autoimmune disorders such as multiple sclerosis, type 1 diabetes and rheumatoid arthritis.
Kartiek Kanduri studied in his doctoral studies carried out at Turku Bioscience Centre what are the gene regulatory pathways T-cells utilize when they become inflammatory.
Using a range of genome-wide omics-methods, deep sequencing and data mining he succeeded to build a holistic picture of a cell when it becomes pathogenic.
– We identified several new factors that mediate differentiation of an inflammatory Th17 cells through a key transcription factor STAT3, Kanduri explains.
Kanduri discovered that STAT3 binds to a number of regulatory regions in the genome that have been associated with autoimmune diseases. The study revealed also several previously unknown long non-coding RNAs, that are specifically expressed early on when a cell differentiates to a particular cell type.
– Many regions that we found to regulate gene activation are in such areas of genome that previously were thought to be ”junk” DNA. We discovered such regions to have autoimmune disease associated genetic variations, single nucleotide polymorphisms or SNPs. Thus such SNPs may contribute to development of immune mediated diseases through regulation of immune response, Kanduri explains.
The results open up new horizons and provide basis for understanding molecular mechanisms of immune mediated diseases.
The papers of the Ph.D. studies have been published in peer-reviewed international journals Genome Medicine (two papers), Cell Reports and Nature Immunology.
***
Kartiek Kanduri will have public defense for his doctoral thesis ”Integration of genome-wide datasets to understand regulation of human T-helper cell differentiation” at University of Turku, Friday June 5th, 2020 at 12 noon.
Due to COVID-19 situation dissertation defences are not arranged as open audience events. Disputant, opponent and custos have to be at least in a voice call. Audience can participate via remote connection.
The opponent is professor Garry Wong (University of Macau, China) and custos academy professor Riitta Lahesmaa (University of Turku). The event is in English. The area of doctoral thesis in medical microbiology and immunology.
Doctoral programme: Turku Doctoral Programme of Molecular Medicine (TuDMM)
Recent Posts
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026
- Rector Widen Visited Our Centre Åbo Akademi University Rector, Gunilla Widén, visited our Centre on Wednesday, February 25th, to learn Read moreFebruary 27, 2026
- Laura Elo is awarded the Leif C. Groop Award for outstanding research on type 1 diabetesLaura Elo a group leader at Turku Bioscience is awarded the Leif C. Groop Award Read moreFebruary 23, 2026
- Finnish Cultural Foundation Awards Funding to Turku Bioscience ResearchersWe are pleased to announce recent funding from The Finnish Cultural Foundation: Congratulations to all Read moreFebruary 16, 2026
- Newly discovered gut microbial molecules in infancy may influence the risk of type 1 diabetesAn international research team has uncovered compelling evidence that gut-microbe-derived molecules may play an important Read moreJanuary 20, 2026
- Turku Bioscience Centre Is Recruiting New Research LeadersTurku Bioscience Centre is currently inviting applications for two key research positions that will strengthen Read moreJanuary 13, 2026